Cannabis Effects on Opioid Self-Administration
Public ClinicalTrials.gov record NCT07668635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Impact of Cannabis on Opioid Self-Administration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can alter the drive/desire to take opioids.
Study identification
- NCT ID
- NCT07668635
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- Cannabis Drug
- Intranasal Opioid Agonist Drug
- Oral Opioid Agonist Drug
- Placebo Cannabis Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2026
- Primary completion
- Jul 29, 2030
- Completion
- Jul 29, 2031
- Last update posted
- Jun 24, 2026
2026 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kentucky Center on Drug and Alcohol Research | Lexington | Kentucky | 40508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cannabis Use trials
Other public records listing Cannabis Use. Sorted by last update posted; newest first. Not a recommendation.
- NCT07725289: Clinician Practice Companion to Address Youth Substance Use Not yet recruiting
- NCT07701304: Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment Recruiting
- NCT07700849: Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement Not yet recruiting
- NCT07694466: Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis Not yet recruiting
- NCT07661446: Cannabis and Opioid Use Disorder, Study 2 Not yet recruiting
- NCT07634835: Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07668635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2026 · Synced Jul 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07668635 live on ClinicalTrials.gov.